Esperion Therapeutics (ESPR) Cash from Investing Activities (QoQ) (2012 - 2024)
Esperion Therapeutics (ESPR) Cash from Investing Activities (QoQ) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -116.88% |
| Jun 30, 2024 | -5.48% |
| Jun 30, 2023 | -30.00% |
| Mar 31, 2023 | 311.97% |
| Dec 31, 2022 | -135.74% |
| Sep 30, 2022 | 560.00% |
| Jun 30, 2022 | 127.62% |
| Mar 31, 2022 | 64.14% |
| Dec 31, 2020 | -643.33% |
| Sep 30, 2020 | -54.34% |
| Jun 30, 2020 | -80.78% |
| Mar 31, 2020 | 1,027.09% |
| Dec 31, 2019 | 46.02% |
| Sep 30, 2019 | -119.89% |
| Jun 30, 2019 | -41.54% |
| Mar 31, 2019 | 18.48% |
| Dec 31, 2018 | -3.65% |
| Sep 30, 2018 | 26.79% |
| Jun 30, 2018 | 4.25% |
| Mar 31, 2018 | -37.43% |